What Is HGH Therapy and Who Actually Needs It?

Here’s the uncomfortable truth at the center of the human growth hormone market: the anti aging and performance optimization industry has built a multi billion dollar market around HGH therapy and almost none of it is FDA approved.

The FDA has never approved HGH for anti aging. It has never approved it for bodybuilding, athletic recovery, general fatigue, or wellness optimization in healthy adults. In the United States, it is actually illegal to prescribe or distribute HGH for any indication that isn’t specifically FDA approved. Yet HGH promoting clinics and offshore pharmacies operate freely, selling the promise of what is essentially a black market anti aging drug to people who may not know what they’re actually taking or what the risks are.

That’s not a fringe issue. The FDA has issued active enforcement alerts about unapproved HGH imports, and a significant French long term cohort study found a 30% higher mortality risk among patients who received recombinant HGH at doses above the approved therapeutic range primarily from bone tumors and cardiovascular events.

None of this means HGH therapy is wrong for everyone. For people with documented growth hormone deficiency, it’s one of the most effective hormonal interventions in endocrine medicine. The distinction between that legitimate use and the wellness marketing version is what every patient deserves to understand clearly.

What Human Growth Hormone Actually Is

Human growth hormone (HGH) also called somatotropin is a peptide hormone produced by the pituitary gland, primarily released in pulses during deep sleep and in response to exercise, fasting, and low blood sugar. It acts on virtually every tissue in the body through two mechanisms: direct receptor binding and by stimulating the liver to produce IGF 1 (insulin like growth factor 1), which is the primary mediator of most of GH’s anabolic effects.

GH’s physiological roles include:

• Promoting linear bone growth in children and adolescents
• Regulating body composition increasing lean muscle mass and reducing body fat, particularly visceral fat
• Supporting protein synthesis and cell repair
• Regulating metabolism of carbohydrates, fats, and proteins
• Supporting immune function and inflammatory regulation
• Influencing mood, cognitive function, and energy

GH production peaks in adolescence and early adulthood, then declines progressively with age falling approximately 14–15% per decade after age 25. By age 60, most adults have significantly lower GH than they did in their 30s. This age related decline in GH is called somatopause, and it contributes to some of the body composition, energy, and cognitive changes associated with aging.

Somatopause is real. Documented, pathological growth hormone deficiency in adults is a different and much less common clinical condition that requires a specific diagnosis and meets specific FDA approved treatment criteria.

FDA Approved Uses: Who Actually Qualifies for HGH Therapy

Synthetic HGH (somatropin) is FDA approved in adults for two primary indications:

1. Adult Growth Hormone Deficiency (AGHD): This is the only adult indication where HGH therapy is broadly appropriate and well evidenced. Adult GHD is caused by damage to or disease of the pituitary gland from pituitary tumors (adenomas), traumatic brain injury, radiation therapy to the brain, or specific pituitary diseases like Sheehan’s syndrome. It can also persist from childhood onset GHD. Diagnosis requires a stimulation test measuring peak GH response to insulin induced hypoglycemia or arginine/GHRH stimulation not just a low IGF 1 level on a routine panel.

Documented adult GHD produces measurable changes: increased visceral fat and reduced lean mass, decreased bone density, reduced exercise capacity, poor lipid profiles, and reduced quality of life. HGH therapy in confirmed AGHD addresses all of these with well documented benefits backed by decades of clinical trial data.

July 2025 FDA approval: The FDA approved Skytrofa (lonapegsomatropin tcgd) for adult GHD a once weekly formulation representing the first significant advance in HGH delivery convenience for adult GHD patients. The foresiGHt Phase 3 trial (259 adults with GHD, double blind, placebo controlled) confirmed efficacy for trunk fat reduction and body composition improvement over 38 weeks, validated by DXA scanning.

2. HIV associated wasting (Serostim): FDA approved for the treatment of AIDS wasting syndrome a specific, serious condition distinct from general weight loss.

Additional pediatric indications include short stature from multiple causes, Turner syndrome, Prader Willi syndrome, and chronic renal failure all outside the adult wellness context.

What HGH Therapy Is NOT Approved For and Why That Matters

The FDA has made its position unambiguous: HGH therapy is not approved for anti aging, athletic performance, bodybuilding, or general wellness in healthy adults. It is illegal to prescribe or distribute HGH for these purposes in the United States, and the FDA has issued import alerts specifically targeting unapproved HGH products.

This is not bureaucratic overreach it reflects real risk data.

Cancer promotion risk: HGH stimulates IGF 1, which promotes cellular proliferation. Elevated IGF 1 has been associated with increased risk of colon, breast, and prostate cancers in observational research. Administering supraphysiologic HGH to people without documented deficiency where GH/IGF 1 systems are already functioning adds a growth stimulus on top of a working system. For people with undiagnosed cancers or pre cancerous lesions, this is not a theoretical risk.

Diabetes risk: HGH is counter regulatory to insulin it promotes insulin resistance at the cellular level. The FDA’s prescribing information for all approved somatropin products carries a prominent warning about glucose intolerance and new onset diabetes mellitus.

Acromegaly like effects: Supraphysiologic HGH doses can produce changes resembling acromegaly the disorder caused by GH secreting tumors including joint pain, carpal tunnel syndrome, fluid retention, organ enlargement, and facial structural changes. These are not reversible once they occur.

The 30% mortality finding: The FDA’s Drug Safety Communication (March 2016, from a large French long term cohort) reported a 30% higher mortality risk among patients treated with above therapeutic HGH doses primarily from bone tumors and cerebrovascular events. This is the study the wellness marketing world consistently omits.

The Age Related GH Decline: What You Can Actually Do Legitimately

Here’s where the conversation gets practical. The somatopause related decline in GH is real and contributes to the body composition and energy changes most people associate with “getting older.” But for healthy adults without documented pituitary disease, the appropriate response is not pharmaceutical HGH it’s supporting the body’s own GH production through evidence based approaches.

What legitimately raises GH naturally:

• Deep sleep is the single largest stimulus for GH release. Growth hormone is primarily secreted during slow wave sleep. How sleep affects your hormones is not optional background reading it’s the most impactful GH intervention for most people.
• High intensity interval training and resistance exercise produce the second largest physiological GH stimulus. Both acutely raise GH through lactate and neural signaling mechanisms.
• Intermittent fasting even short 12–16 hour fasting windows significantly boosts GH pulse amplitude by reducing insulin, which suppresses GH release.
• Reducing visceral fat high visceral fat loads blunt GH secretion through somatostatin and free fatty acid feedback. Cortisol and belly fat is directly relevant here.

Growth hormone secretagogues the middle path: Sermorelin and CJC 1295/Ipamorelin are peptide based GH secretagogues that stimulate the pituitary to produce more of its own GH, rather than introducing exogenous HGH. Sermorelin has prior FDA approval history (it was approved as a diagnostic tool before voluntary market withdrawal by its manufacturer) and is available through regulated compounding pharmacies under physician oversight. CJC 1295/Ipamorelin are currently restricted from compounding pending FDA advisory review as covered in detail in what is peptide therapy.

The key advantage: secretagogues work within the body’s regulatory feedback system rather than bypassing it, which limits the risk of supraphysiologic exposure and maintains more natural pulsatile GH release patterns.

For men with declining testosterone alongside suspected GH axis dysfunction, signs of dropping testosterone and what a comprehensive hormone panel tests for are the starting points because testosterone itself stimulates GH secretion, and low testosterone may be the proximate driver of GH axis decline in many men.

Conclusion: Real Deficiency Deserves Real Treatment But Testing Comes First

HGH therapy is genuinely transformative for people with documented adult growth hormone deficiency. The clinical evidence and the July 2025 once weekly Skytrofa approval demonstrate that this is a well characterized, well treated condition with meaningful quality of life impact.

It is not appropriate, evidence supported, or legal for healthy adults seeking anti aging or performance benefits and the risk data is specific enough to warrant taking that seriously.

If you’re experiencing symptoms that might suggest GH axis dysfunction persistent fatigue, body composition changes despite effort, cognitive sluggishness, reduced exercise tolerance the right first step is proper testing, not a prescription from a wellness clinic that doesn’t require a stimulation test.

At AK Twisted Wellness, we evaluate hormonal health comprehensively including IGF 1, growth hormone context, testosterone, thyroid, and adrenal function before making any treatment recommendations. We don’t prescribe HGH for unapproved indications, and we don’t pretend that’s a gap in our services. We build comprehensive protocols using evidence based tools that are appropriate for your specific biology.

Visit aktw.life or call (520) 710 8805 telehealth available nationwide.

Frequently Asked Questions

1. What is HGH therapy used for? FDA approved HGH therapy (somatropin) is used for documented adult growth hormone deficiency (typically caused by pituitary disease, brain trauma, or radiation), HIV associated wasting, and multiple specific pediatric growth conditions. It is not FDA approved for anti aging, bodybuilding, athletic performance enhancement, or general wellness in healthy adults and in the United States, it is illegal to prescribe or distribute HGH for unapproved indications.

2. Can HGH therapy help with aging and body composition? For people with documented growth hormone deficiency, HGH therapy produces meaningful improvements in lean mass, visceral fat, bone density, lipid profiles, and quality of life. For healthy adults with normal GH production experiencing age related GH decline (somatopause), the evidence does not support pharmaceutical HGH the risks outweigh the modest benefits, and the treatment is not legally available for this use. Growth hormone secretagogues like sermorelin offer a potentially safer alternative by stimulating the body’s own GH production rather than replacing it.

3. What are the risks of HGH therapy? Real and documented risks include glucose intolerance and new onset diabetes (HGH opposes insulin at the cellular level), increased cancer risk related to IGF 1 elevation at supraphysiologic doses, acromegaly like effects (joint pain, carpal tunnel, fluid retention, facial changes) at excessive doses, intracranial hypertension, and a 30% increased mortality risk identified in a large French cohort study for patients treated with above approved doses. These risks are dose dependent and are more common with unapproved, non medically supervised use.

4. What is the difference between HGH and growth hormone secretagogues like sermorelin? Exogenous HGH directly replaces growth hormone bypassing the pituitary’s regulatory system and potentially producing supraphysiologic levels. Growth hormone secretagogues stimulate the pituitary to produce more of its own GH through existing feedback mechanisms, maintaining more natural pulsatile release and limiting the risk of oversupply. Sermorelin has a prior FDA approval history and is available through regulated compounding pharmacies; CJC 1295 and Ipamorelin are currently restricted pending FDA advisory review. Full peptide therapy context here.

5. How is adult growth hormone deficiency diagnosed? Diagnosis of adult GHD requires a stimulation test typically an insulin tolerance test (ITT) or GHRH arginine stimulation test that measures peak GH response under provoked conditions. A random serum IGF 1 or single fasting GH level is insufficient for diagnosis because GH is secreted in pulses and circulating IGF 1 can be normal in some GHD cases. The diagnosis also requires clinical context a history of pituitary disease, brain surgery, head trauma, or childhood GHD is typically required before stimulation testing is indicated.

6. How does AK Twisted Wellness approach HGH and the GH axis? We evaluate IGF 1, testosterone, thyroid function, adrenal markers, and body composition context as part of comprehensive hormonal assessments because the symptoms associated with GH decline often reflect several hormonal systems simultaneously. We work with sermorelin where appropriate and clinically indicated under regulated prescribing frameworks. We do not prescribe synthetic HGH for anti aging or performance indications, and we’re transparent about why. Visit aktw.life or call (520) 710 8805.

References

1. Mayo Clinic. (2024). Human Growth Hormone (HGH): Does It Slow Aging? https://www.mayoclinic.org/healthy lifestyle/healthy aging/in depth/growth hormone/art 20045735
2. WebMD. (2024). Human Growth Hormone (HGH): Benefits, Risks, and Uses. Medically reviewed. https://www.webmd.com/fitness exercise/human growth hormone hgh
3. Aetna Clinical Policy. (2025). Growth Hormone (GH) and Growth Hormone Antagonists FDA Approvals and Coverage Policy. https://www.aetna.com/cpb/medical/data/100_199/0170.html
4. U.S. Food & Drug Administration. (2025). FDA Approves Skytrofa (Lonapegsomatropin) for Adult Growth Hormone Deficiency July 28, 2025. https://www.aetna.com/cpb/medical/data/100_199/0170.html
5. U.S. Food & Drug Administration. (2016). FDA Drug Safety Communication: Ongoing Safety Review of Recombinant Human Growth Hormone (Somatropin) and Possible Increased Risk of Death. https://www.fda.gov/drugs/drug safety and availability/fda drug safety communication ongoing safety review recombinant human growth hormone somatropin and
6. Norditropin (Somatropin) Prescribing Information. (July 2025). Novo Nordisk FDA Approved Indications and Warnings. https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/021148s062lbl.pdf
7. Endocrine Society. (2024). Growth Hormone Deficiency in Adults Clinical Practice Guideline. https://www.endocrine.org/clinical practice guidelines/growth hormone deficiency in adults
8. National Institute of Diabetes and Digestive and Kidney Diseases. (2024). Growth Hormone Deficiency Information for Adults. https://www.niddk.nih.gov/health information/endocrine diseases
9. Healthline. (2024). Human Growth Hormone (HGH): Everything You Need to Know. Medically reviewed by Stacy Sampson, D.O. https://www.healthline.com/health/growth hormone
10. Cleveland Clinic. (2024). Human Growth Hormone (HGH): What It Is and What It Does. https://my.clevelandclinic.org/health/body/23309 human growth hormone
    

Disclaimer: This content is for informational and educational purposes only and does not constitute medical, legal, or financial advice. Reading this article does not create a patient provider relationship. HGH therapy is a prescription only drug with a specific, legally defined indication in the United States it is illegal to prescribe or use for unapproved purposes. Never begin any hormone therapy without proper diagnostic testing and guidance from a licensed healthcare provider. For questions about AK Twisted Wellness services, visit aktw.life or call (520) 710 8805.